Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Marges de sécurité échographiques de la veine sous-clavière : effet de la vue et de la position du bras

17 septembre 2026 mis à jour par: Jun-Young Park, Asan Medical Center

Étude observationnelle par échographie de l'anatomie de la veine sous-clavière : comparaison des marges de sécurité entre les positions supraclaviculaire et infraclaviculaire selon la position du bras

The purpose of this observational study is to evaluate and compare the anatomical safety margins of the subclavian vein using ultrasound. Medical professionals commonly use the subclavian vein to insert central venous catheters, but nearby vulnerable structures, such as the lung and artery, can be at risk during the procedure.

This study investigates two different ultrasound probe positions: supraclavicular (above the collarbone) and infraclavicular (below the collarbone). It also examines how changing the patient's arm position (from resting in a neutral position to being raised at a 90-degree angle) affects the distance between the vein and these vulnerable structures.

Participants are adult patients scheduled for surgery under general anesthesia who already require ultrasound-guided vascular access. Immediately after falling asleep from anesthesia, researchers will perform a brief 3 to 5-minute ultrasound scan of the collarbone area. This is a strictly non-invasive imaging study; no research-related needle punctures or catheter insertions will be performed. The findings aim to provide robust anatomical evidence to make future vascular procedures safer for patients.

Aperçu de l'étude

Description détaillée

Central venous catheterization via the subclavian vein (SCV) is clinically favored due to its lower infection and thrombosis rates. However, traditional landmark-guided approaches carry the risk of mechanical complications, including pneumothorax and inadvertent arterial puncture. While real-time ultrasound guidance is strongly recommended to minimize these risks, there is an ongoing debate regarding the optimal probe position-specifically, the supraclavicular (SC) versus the infraclavicular (IC) view. Furthermore, clinical practitioners frequently utilize arm abduction to facilitate venous access, yet its dynamic effect on the anatomical safety margin (the distance between the SCV and adjacent vulnerable structures like the subclavian artery [SCA] and pleura) remains insufficiently quantified.

This prospective, non-invasive observational study aims to address this knowledge gap. The study will enroll 55 adult patients scheduled to undergo

Study Protocol:

Timing: Immediately following the induction of general anesthesia, during the standard pre-procedural preparation period, a brief (approximately 3 to 5 minutes) ultrasound assessment will be conducted.

Imaging: An investigator will obtain short-axis ultrasound views of the SCV from both the SC and IC positions.

Positioning: In each ultrasound view, measurements will be recorded under two different patient arm positions: neutral (adducted alongside the torso) and 90-degree abduction.

Data Acquisition: All ultrasound images will be captured at the end-expiratory phase and saved for offline analysis.

Safety: The study involves solely non-invasive sonographic observation; no research-specific needle puncture, cannulation, or catheterization will be performed. Routine scheduled clinical care and procedures will proceed immediately after the brief image acquisition is complete.

By analyzing sonographic parameters such as the SCV-SCA distance, vessel cross-sectional areas, depth to the pleura, and the SCV-SCA overlap index, this study seeks to elucidate the most secure anatomical window. Ultimately, the data will establish safer, evidence-based guidelines for patient positioning and ultrasound probe placement during SCV access.

Type d'étude

Observationnel

Inscription (Réel)

55

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

20 ans à 79 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Need for ultrasound-guided vascular access for general anesthesia

La description

Inclusion Criteria:

  • Patients requiring ultrasound-guided vascular procedures.
  • Age between 20 and 79 years.
  • Patients who have voluntarily provided written informed consent for this clinical study.
  • American Society of Anesthesiologists (ASA) physical status classification I, II, or III.

Exclusion Criteria:

  • Anatomical variations of the clavicle (e.g., history of clavicle fracture).
  • Suspected thrombosis at the target site.
  • Known anatomical abnormalities of the subclavian vein or artery.
  • Inability to abduct the arm (e.g., due to shoulder joint abnormalities).
  • Patient refusal to participate.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Modèles d'observation: CASE_ONLY
  • Perspectives temporelles: PROSPECTIVE

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
Observation Group

Adult patients undergoing general anesthesia who are scheduled for ultrasound-guided vascular catheterization.

Non-invasive ultrasound measurement of anatomical safety margins of the subclavian vein and adjacent structures, comparing supraclavicular and infraclavicular views in neutral and abducted arm positions.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Shortest Distance Between the Subclavian Vein (SCV) and Subclavian Artery (SCA)
Délai: Immediately after the induction of general anesthesia (within 3 to 5 minutes)

The shortest anatomical distance between the SCV and SCA is measured in the neutral arm position to evaluate the safety margin. The difference between the supraclavicular (SC) and infraclavicular (IC) views will be analyzed using a paired t-test or Wilcoxon signed-rank test.

Immediately after the induction of general anesthesia (within 3 to 5 minutes)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Sonographic Continuous Variables of the SCV and Adjacent Structures
Délai: Immediately after the induction of general anesthesia (within 3 to 5 minutes)

The following continuous variables will be measured: 1) distance between SCV and SCA, 2) distance from skin to the anterior and posterior walls of SCV, 3) distance from SCV posterior wall to the pleura. These parameters will be analyzed using a two-way repeated measures ANOVA to assess the effects of the probe view (SC vs. IC) and arm position (neutral vs. abduction).

Immediately after the induction of general anesthesia (within 3 to 5 minutes)
Sonographic Cross-Sectional Area (CSA) Variables of the SCV and Adjacent Structures
Délai: Immediately after the induction of general anesthesia (within 3 to 5 minutes)

The following continuous variables regarding area and dimension will be measured: 1) transverse length and cross-sectional area (CSA) of the SCV, and 2) CSA of the SCA. These parameters will be analyzed using a two-way repeated measures ANOVA to assess the effects of the probe view (SC vs. IC) and arm position (neutral vs. abduction).

Immediately after the induction of general anesthesia (within 3 to 5 minutes)
Sonographic Proportion and Index Variables of the SCV and Adjacent Structures
Délai: Immediately after the induction of general anesthesia (within 3 to 5 minutes)

The following continuous variables regarding proportions will be measured: 1) SCV-SCA overlap index (%), and 2) clavicle shadowing proportion (%). These parameters will be analyzed using a two-way repeated measures ANOVA to assess the effects of the probe view (SC vs. IC) and arm position (neutral vs. abduction).

Immediately after the induction of general anesthesia (within 3 to 5 minutes)
Relative Position of the Subclavian Artery (SCA) to the Subclavian Vein (SCV)
Délai: Immediately after the induction of general anesthesia (within 3 to 5 minutes)

A nominal variable describing the anatomical location of the SCA relative to the SCV (e.g., medial, posteromedial, posterior). The distribution changes according to the probe view (SC vs. IC) and arm position (neutral vs. abduction) will be compared using Generalized Estimating Equations (GEE).

Immediately after the induction of general anesthesia (within 3 to 5 minutes)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Réel)

30 avril 2026

Achèvement primaire (Réel)

10 juin 2026

Achèvement de l'étude (Réel)

10 juin 2026

Dates d'inscription aux études

Première soumission

22 avril 2026

Première soumission répondant aux critères de contrôle qualité

22 avril 2026

Première publication (Réel)

29 avril 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

21 septembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

17 septembre 2026

Dernière vérification

1 juin 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 2026-0533

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

NON

Description du régime IPD

Individual participant data (IPD) will not be shared to protect patient privacy and confidentiality, in accordance with the Institutional Review Board (IRB) regulations. Only aggregated and anonymized data will be presented in the final publication.

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

produit fabriqué et exporté des États-Unis.

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner